Amalgamated Bank’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Amalgamated Bank’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,708	Closed	-$225K	–	1639
2020 Q4	$225K	Buy	+1,708	New	+$151K	0.01%	1384

Amalgamated Bank's EIDX Position: Q1 2021 in Review

Amalgamated Bank sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 1,708 shares — an estimated $225K sold.

Amalgamated Bank first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $225K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Amalgamated Bank reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Amalgamated Bank sold 1,708 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $225K.
Amalgamated Bank first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Amalgamated Bank's Eidos Therapeutics, Inc. Common Stock position peaked at $225K in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Amalgamated Bank's 13F filing for Q1 2021, filed 13 May 2021.